RCMU
CABA icon

Rokos Capital Management (UK)’s Cabaletta Bio CABA Stock Holding History

Rokos Capital Management (UK)’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-80,335
Closed -$1.82M – 93
2023
Q4 		$1.82M Sell
80,335
-93,515
-54% -$1.57M 0.02% 65
2023
Q3 		$2.67M Hold
173,850
– – 0.02% 91
2023
Q2 		$2.25M Buy
+173,850
New +$1.89M 0.02% 82

Other funds holding CABA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Rokos Capital Management (UK)'s CABA Position: Q1 2024 in Review

Rokos Capital Management (UK) sold out of Cabaletta Bio (CABA) in Q1 2024, closing a stake of 80,335 shares — an estimated $1.82M sold.

Rokos Capital Management (UK) first reported a position in CABA in Q2 2023 and held it in 3 quarters. The position peaked at $2.67M in Q3 2023. 159 funds tracked by Wall St. Rank hold CABA as of Q1 2024.

  • Rokos Capital Management (UK) reported no remaining Cabaletta Bio position as of Q1 2024 after selling out during the quarter.
  • Rokos Capital Management (UK) sold 80,335 Cabaletta Bio shares in Q1 2024, an estimated $1.82M.
  • Rokos Capital Management (UK) first reported a position in Cabaletta Bio in Q2 2023 and held it in 3 quarters.
  • Rokos Capital Management (UK)'s Cabaletta Bio position peaked at $2.67M in Q3 2023.
  • 159 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2024.

Based on Rokos Capital Management (UK)'s 13F filing for Q1 2024, filed 15 May 2024.